Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Taysha Gene Therapies Inc
(NQ:
TSHA
)
2.165
+0.125 (+6.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Taysha Gene Therapies Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Taysha Gene Therapies Secures up to $100 Million Non-Dilutive Term Loan Financing
August 16, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
Taysha Gene Therapies to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 16
August 09, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
Taysha Gene Therapies to Participate in Upcoming August Investor Healthcare Conferences
August 02, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
Taysha Gene Therapies to Host Manufacturing Day
July 20, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
What 8 Analyst Ratings Have To Say About Taysha Gene Therapies
July 16, 2021
Analysts have provided the following ratings for Taysha Gene Therapies (NASDAQ:
Via
Benzinga
What 9 Analyst Ratings Have To Say About Taysha Gene Therapies
June 24, 2021
Taysha Gene Therapies (NASDAQ:TSHA) has observed the follo...
Via
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-118 for the Treatment of CLN1 Disease
August 17, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
Taysha Gene Therapies, Inc. (TSHA) Q2 2021 Earnings Call Transcript
August 16, 2021
TSHA earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Taysha Gene Secures $100M In Debt Financing For Support Pipeline Development
August 16, 2021
Taysha Gene Therapies Inc (NASDAQ: TSHA) has entered into a loan and security agreement with Silicon Valley Bank (SVB), providing up to $100 million of...
Via
Benzinga
Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 16, 2021
From
Taysha Gene Therapies
Via
Business Wire
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For August 16, 2021
August 16, 2021
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to...
Via
Benzinga
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
July 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
July 12, 2021
Gainers Celldex Therapeutics (NASDAQ:CLDX) stock increased by 21.35% to $39.33 during Monday's regular session. Celldex Therapeutics's stock is trading at a volume...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 27, 2021
During Tuesday's morning session, 216 companies made new 52-week lows. Noteworthy Points: Alibaba Group Holding (NYSE:BABA) was the largest firm by market cap...
Via
Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021
July 16, 2021
Upgrades According to Citigroup, the prior rating for Alcoa Corp (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 09, 2021
Gainers Galectin Therapeutics (NASDAQ:GALT) shares moved upwards by 35.0% to $3.73 during Friday's regular session. As of 12:30 EST, Galectin Therapeutics's stock...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
July 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 08, 2021
Thursday morning, 158 companies reached new 52-week lows. Noteworthy Highlights: The largest company in terms of market cap to set a new 52-week low was Alibaba...
Via
Benzinga
Taysha Gene Therapies to Participate in Upcoming July Investor Healthcare Conference
July 08, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
July 01, 2021
Gainers Alterity Therapeutics (NASDAQ:ATHE
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 25, 2021
Gainers Osmotica Pharmaceuticals (NASDAQ:OSMT) stock increased by 39.78% to $3.97 during Friday's regular session. The current volume of 48.4 million shares is 18988....
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021
June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE:
Via
Benzinga
Taysha Gene Therapies Announces Publication of Natural History Data for TSHA-120 in Giant Axonal Neuropathy in the Journal, Brain
June 21, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
Taysha Gene Therapies to Host Virtual R&D Day
June 17, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
Analyst Ratings for Taysha Gene Therapies
June 15, 2021
Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 1...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...
Via
Benzinga
Taysha Gene Therapies to Participate in Upcoming Investor Healthcare Conference and CEO Forum
June 15, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.